Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2014
Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate-resistant prostate cancer
David Thomson, Natalie Charnley, Omi Parikh
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2006
Clinical molecular imaging with positron emission tomography
Azeem Saleem, Natalie Charnley, Pat Price
Methods in Molecular Biology (Clifton, N.J.)
|
March 24, 2009
Imaging angiogenesis
Natalie Charnley, Stephanie Donaldson, Pat Price
Cancer Treatment Reviews
|
July 7, 2024
Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review
Janet Brown, Daniele Santini, Natalie Charnley, et al.
Future Oncology (London, England)
|
October 19, 2019
Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis
Michael Moran, Dana Nickens, Katherine Adcock, et al.
Targeted Oncology
|
July 14, 2019
Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data
Michael Moran, Dana Nickens, Katherine Adcock, et al.
BJU International
|
September 12, 2024
A decade long insight into patient views on kidney cancer care delivery
Sabrina H Rossi, Geraldine Fox, Malcolm Packer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 20, 2009
Optimization of the injected activity in dynamic 3D PET: a generalized approach using patient-specific NECs as demonstrated by a series of 15O-H2O scans
Matthew D Walker, Julian C Matthews, Marie-Claude Asselin, et al.
Targeted Oncology
|
June 7, 2023
Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis
Jonathan Heseltine, Jennifer Allison, Sam Wong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 2006
Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy
Natalie Charnley, Catharine M West, Carolyn M Barnett, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2014
Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate-resistant prostate cancer
David Thomson, Natalie Charnley, Omi Parikh
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2006
Clinical molecular imaging with positron emission tomography
Azeem Saleem, Natalie Charnley, Pat Price
Methods in Molecular Biology (Clifton, N.J.)
|
March 24, 2009
Imaging angiogenesis
Natalie Charnley, Stephanie Donaldson, Pat Price
Cancer Treatment Reviews
|
July 7, 2024
Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review
Janet Brown, Daniele Santini, Natalie Charnley, et al.
Future Oncology (London, England)
|
October 19, 2019
Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis
Michael Moran, Dana Nickens, Katherine Adcock, et al.
Targeted Oncology
|
July 14, 2019
Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data
Michael Moran, Dana Nickens, Katherine Adcock, et al.
BJU International
|
September 12, 2024
A decade long insight into patient views on kidney cancer care delivery
Sabrina H Rossi, Geraldine Fox, Malcolm Packer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 20, 2009
Optimization of the injected activity in dynamic 3D PET: a generalized approach using patient-specific NECs as demonstrated by a series of 15O-H2O scans
Matthew D Walker, Julian C Matthews, Marie-Claude Asselin, et al.
Targeted Oncology
|
June 7, 2023
Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis
Jonathan Heseltine, Jennifer Allison, Sam Wong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 2006
Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy
Natalie Charnley, Catharine M West, Carolyn M Barnett, et al.
Page
of 2